RAC ASX News

4 December 2024

Race Submits Human Ethics for RC220 Phase 1 Trial

Race Oncology advances RC220 trial with ethics application submission.

Race Oncology RC220 Clinical Trials Cancer Treatment Stock Market News

Posted on: 04/12/2024

20 November 2024

Race Discovers Multiple Novel FTO Inhibitor Candidates

Race Oncology discovers 39 novel FTO inhibitor candidates for cancer therapy.

Race Oncology FTO Inhibitors Cancer Treatment Biotechnology Stock Market News

Posted on: 20/11/2024

29 July 2024

Bisantrene Phase 2 AML Trial Successful Concludes

Race Oncology's Phase 2 trial of bisantrene for AML meets efficacy criteria.

Race Oncology Bisantrene AML Clinical Trials Stock Market News

Posted on: 29/07/2024

23 July 2024

Quarterly Activity Report and Appendix 4C

Race Oncology announces key advancements in RC220 bisantrene development.

Race Oncology RC220 bisantrene FDA Designation Clinical Trials Stock Market News

Posted on: 23/07/2024